According to Joe's statements in several of past CCs, these mentioned acquisitions are each one a piece of the puzzle that he wants to fit together into a fully integrated enterprise.
According to the same re-iterated statement, GNBT is still in the final stages of the re-organisation program, which should conclude at least in the IPO of NGIO, and once that re-org. is done, he will continue to fit all those pieces of the puzzle together. So neither you nor I have more than a glimpse of what GNBT looks like in the vision that Joe has for this company in the final stage of the enterprise that he has in mind. Everything is significantly delayed, due to the financial issues (partly inflicted by the ~90% decline in pps, which is a result of the VP and CMF fraudulent behaviour last year) on the one hand, and the SEC now obviously taking GNBT more serious, as they learned about their ambitions to be listed on a national exchange, and thus taking the entire last 10-K apart and analyse every single bit of it, which took 10+ months, in total (be it the SEC causing it to be so long, or GNBT not responding quickly enough, I am not sure).
That the SEC takes that much effort to review GNBT's 10-K could also be seen as a clear sign that they are now considering GNBT as a tangible prospect for a Nasdaq listed company!?
Oh, and I did ask Todd about the missing NGIO CC replay, and he said that he does not consider it an obligation to make that publicly available, as NGIO is not yet a publicly traded company. So we can be rest assured, that once NGIO will be listed on a stock exchange, those CC replays will be made available to us. Like it or not, but that was what Todd answered me to my related question.
Generex Biotechnology Corp. (GNBT) Stock Research Links